Morgan Stanley’s Solid Biosciences SLDB Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$1.15M Sell
235,649
-118,073
-33% -$575K ﹤0.01% 5027
2025
Q1
$1.31M Buy
353,722
+275,739
+354% +$1.02M ﹤0.01% 4869
2024
Q4
$312K Buy
77,983
+12,976
+20% +$51.9K ﹤0.01% 5624
2024
Q3
$453K Buy
65,007
+8,634
+15% +$60.2K ﹤0.01% 5448
2024
Q2
$320K Buy
56,373
+34,188
+154% +$194K ﹤0.01% 5484
2024
Q1
$296K Buy
22,185
+13,719
+162% +$183K ﹤0.01% 5568
2023
Q4
$52K Buy
8,466
+3,868
+84% +$23.8K ﹤0.01% 6373
2023
Q3
$11.6K Sell
4,598
-20
-0.4% -$50 ﹤0.01% 6680
2023
Q2
$24.2K Hold
4,618
﹤0.01% 6503
2023
Q1
$21.9K Sell
4,618
-69
-1% -$327 ﹤0.01% 6593
2022
Q4
$25.2K Sell
4,687
-2,040
-30% -$11K ﹤0.01% 6583
2022
Q3
$47K Sell
6,727
-3,807
-36% -$26.6K ﹤0.01% 6439
2022
Q2
$97K Buy
10,534
+2,384
+29% +$22K ﹤0.01% 6291
2022
Q1
$147K Sell
8,150
-15,957
-66% -$288K ﹤0.01% 6087
2021
Q4
$632K Buy
24,107
+18,014
+296% +$472K ﹤0.01% 5401
2021
Q3
$217K Sell
6,093
-6,656
-52% -$237K ﹤0.01% 5960
2021
Q2
$701K Buy
12,749
+764
+6% +$42K ﹤0.01% 5305
2021
Q1
$994K Sell
11,985
-1,565
-12% -$130K ﹤0.01% 4736
2020
Q4
$1.54M Buy
13,550
+6,846
+102% +$779K ﹤0.01% 4374
2020
Q3
$204K Sell
6,704
-28,991
-81% -$882K ﹤0.01% 5108
2020
Q2
$1.57M Sell
35,695
-1,642
-4% -$72.2K ﹤0.01% 3811
2020
Q1
$1.34M Sell
37,337
-8,938
-19% -$320K ﹤0.01% 3721
2019
Q4
$3.09M Buy
46,275
+21,627
+88% +$1.44M ﹤0.01% 3676
2019
Q3
$3.82M Buy
24,648
+23,476
+2,003% +$3.64M ﹤0.01% 3166
2019
Q2
$101K Sell
1,172
-2,454
-68% -$211K ﹤0.01% 5318
2019
Q1
$501K Buy
3,626
+2,130
+142% +$294K ﹤0.01% 4549
2018
Q4
$601K Sell
1,496
-1,511
-50% -$607K ﹤0.01% 4667
2018
Q3
$2.13M Buy
3,007
+1,557
+107% +$1.1M ﹤0.01% 3952
2018
Q2
$776K Buy
1,450
+98
+7% +$52.4K ﹤0.01% 4792
2018
Q1
$152K Buy
+1,352
New +$152K ﹤0.01% 5576